Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Physical polymer matrices based on affinity interactions between peptides and polysaccharides.

Brandon L Seal1, Alyssa Panitch

  • 1The Harrington Department of Bioengineering, Arizona State University, P.O. Box 879709, Tempe, Arizona 85287-9709, USA.

Biomacromolecules
|November 11, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular and Antiangiogenic Effects of Paclitaxel-Loaded Nanoparticles: Influence of the Nanocarrier Type.

Molecular pharmaceutics·2026
Same author

Loading of therapeutic cell penetrating peptides into extracellular vesicles for pulmonary fibrosis.

Journal of controlled release : official journal of the Controlled Release Society·2025
Same author

Disturbed flow induces reprogramming of endothelial cells to immune-like and foam cells under hypercholesterolaemia during atherogenesis.

Cardiovascular research·2025
Same author

Chondrogenic and chondroprotective response of composite collagen I/II-hyaluronic acid scaffolds within an inflammatory osteoarthritic environment.

Biomaterials science·2025
Same author

Disturbed Flow Induces Reprogramming of Endothelial Cells to Immune-like and Foam Cells under Hypercholesterolemia during Atherogenesis.

Research square·2025
Same author

Disturbed Flow Induces Reprogramming of Endothelial Cells to Immune-like and Foam Cells under Hypercholesterolemia during Atherogenesis.

bioRxiv : the preprint server for biology·2025

A novel polymer matrix using heparin and peptides offers controlled drug release. By adjusting peptide affinity, therapeutic delivery rates can be precisely managed for in vivo applications.

Area of Science:

  • Biomaterials Science
  • Polymer Chemistry
  • Drug Delivery Systems

Background:

  • Developing advanced materials for controlled therapeutic release is crucial.
  • Polymer matrices offer versatile platforms for drug delivery applications.
  • Heparin and heparin-binding peptides present unique interaction possibilities for material design.

Purpose of the Study:

  • To create a rapidly forming polymer matrix with tunable, affinity-based controlled release properties.
  • To investigate the mechanical and recovery characteristics of the developed biopolymer mixture.
  • To demonstrate the controlled release of heparin-binding peptides from the matrix based on their affinity.

Main Methods:

  • Synthesized a polymer matrix from poly(ethylene glycol)-co-peptide and heparin.

Related Experiment Videos

  • Characterized the matrix's viscoelastic properties using dynamic mechanical testing.
  • Assessed the matrix's ability to sequester and release exogenous heparin-binding peptides.
  • Quantified peptide release rates based on varying heparin affinities.

    • Main Results:

    • The 10% (w/v) polymer-heparin matrix exhibited a viscoelastic profile akin to concentrated polymer solutions.
    • The biopolymer mixtures demonstrated rapid recovery after thermal denaturation and mechanical stress.
    • The matrix successfully sequestered heparin-binding peptides, releasing them over several days.
    • Release rates varied significantly, from 3.3% per hour (low affinity) to 0.025% per hour (strong affinity).

    Conclusions:

    • A novel, rapidly forming polymer matrix with controlled release capabilities was successfully developed.
    • The release kinetics can be precisely modulated by altering the affinity between peptides and heparin.
    • This system holds significant potential for controlled in vivo delivery of therapeutics by tailoring peptide-heparin interactions.